U.S. Senators Charles E. Schumer and Kirsten Gillibrand today announced that the American Recovery and Reinvestment Act (ARRA) will provide a total of $1,346,463 to two research institutions in Western NY through the National Institutes for Health. The University at Buffalo will receive $212,022 and the Roswell Park Cancer Institute (RPCI) will receive $1,134,441. This funding will create jobs for those in the field and bolster research efforts on important areas of medicine. A total of $9.9 million will be administered to New York State research institutions.
“These projects will invest in cutting-edge medical research at the University at Buffalo and the Roswell Park Cancer Institute,” said Senator Schumer. “This funding will not only give an economic boost in the amount of jobs available in Western New York, but will bring us another step closer to solving public health problems afflicting many New Yorkers. Our federal dollars must continue to emphasize the importance of medical research in solving today’s public health problems and giving our students the tools they need to succeed.”
“It is critical that we invest in the life-saving research and personnel training at our world class medical facilities in Buffalo,” said Senator Gillibrand. “Federal funding for these cutting edge research and training programs will help with medical diagnosis and treatment while promoting economic growth in Western New York. I will continue to work with Senator Schumer to ensure New York gets its fair share of federal dollars.”
The funding breaks down as follows:
- $20,478 to University at Buffalo for summer research opportunities
- $191,544 to University at Buffalo for study of Genomic and Cellular Markers and Chronic Renal Allograft Function
- $145,399 to RPCI for study of SES, Race and Patterns of Health Care Navigation of Parents of Pediatric Cancer Patients
- $356,346 to RPCI for study of Targeting the proteasome to overcome therapy resistance in B-NHL
- $335,208 to RPCI for study of PDEF and survivin: cancer prognosis, initiation, progression and metastasis
- $297,488 to RPCI for study of ST6Gal-1 Sialyltransferase in Allergic Airway Inflammation
Founded as a private university in 1846, the University at Buffalo joined the SUNY system in 1962 and has become a leader in scientific research at the university level. The grant money received by the institution will allow researchers to test whether patient race or gender affect immunosuppression drug responses in kidney transplant recipients. The university will receive a total of $212,022.
The Roswell Park Cancer Institute (RPCI) is a state-affiliated cancer research center located in Buffalo that investigates all aspects of the disease. The grants received by the facility will target topics from drug and treatment development to parental navigation of the health care community after a child’s diagnosis advancements in prognosis techniques. The institute will received a total of $1,134,441.
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research. Helping to lead the way toward important medical discoveries that improve people’s health and save lives, the NIH provides leadership and financial support to more than 3,000 institutions in the fifty states and territories.